Patents by Inventor John M. Yanni

John M. Yanni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of an anti-allergy agent and a steroid to treat nasal conditions
    Publication number: 20040097474
    Abstract: Compositions and methods for treating rhinitis with certain combinations of antiallergic agents and steroids are disclosed.
    Type: Application
    Filed: November 12, 2003
    Publication date: May 20, 2004
    Applicant: Alcon, Inc.
    Inventors: Gerald D. Cagle, G. Michael Wall, John M. Yanni, Rajni Jani, Haresh G. Bhagat
  • Antibiotic compositions for treatment of the eye, ear and nose
    Publication number: 20040097512
    Abstract: Ophthalmic, otic and nasal compositions containing a new class of antibiotics (e.g., moxifloxacin) are disclosed. The compositions preferably also contain one or more anti-inflammatory agents. The compositions may be utilized to treat ophthalmic, otic and nasal conditions by topically applying the compositions to the affected tissues.
    Type: Application
    Filed: November 17, 2003
    Publication date: May 20, 2004
    Inventors: Gerald Cagle, Robert L. Abshire, David W. Stroman, John M. Yanni
  • Use of an H1 antagonist and a safe steroid to treat eye conditions
    Publication number: 20040097486
    Abstract: Compositions and methods for treating VKC, GPC, AKC and allergic conjunctivitis with H1 antagonists and ocularly safe steroids are disclosed.
    Type: Application
    Filed: November 7, 2003
    Publication date: May 20, 2004
    Inventor: John M. Yanni
  • Ophthalmic antibiotic compositions containing moxifloxacin
    Patent number: 6716830
    Abstract: Ophthalmic, otic and nasal compositions containing a new class of antibiotics (e.g., moxifloxacin) are disclosed. The compositions preferably also contain one or more anti-inflammatory agents. The compositions may be utilized to treat ophthalmic, otic and nasal conditions by topically applying the compositions to the affected tissues.
    Type: Grant
    Filed: July 22, 2002
    Date of Patent: April 6, 2004
    Assignee: Alcon, Inc.
    Inventors: Gerald Cagle, Robert L. Abshire, David W. Stroman, John M. Yanni
  • Use of NF-&kgr;B inhibitors to treat dry eye disorders
    Patent number: 6696453
    Abstract: NF-&kgr;B inhibitors are useful for treating dry eye disorders and other disorders requiring the wetting of the eye.
    Type: Grant
    Filed: May 17, 2002
    Date of Patent: February 24, 2004
    Assignee: Alcon, Inc.
    Inventors: Daniel A. Gamache, John M. Yanni
  • Use of hydroxyeicosatetraenoic acid compounds to treat vaginal dryness
    Publication number: 20030236284
    Abstract: The use of HETE compounds to treat vaginal dryness is disclosed.
    Type: Application
    Filed: April 9, 2003
    Publication date: December 25, 2003
    Applicant: Alcon, Inc.
    Inventors: John M. Yanni, Daniel A. Gamache, Michael Van Wie Bergamini
  • Use of an H1 antagonist and a safe steroid to treat eye conditions
    Patent number: 6649602
    Abstract: Composition and method of treating VKC, GPC, and AKC with H1 antagonists and ocularly safe steroids are disclosed.
    Type: Grant
    Filed: February 28, 2002
    Date of Patent: November 18, 2003
    Assignee: Alcon, Inc.
    Inventor: John M. Yanni
  • Method of treating ocular inflammatory and angiogenesis-related disorders of the posterior segment of the eye using an amide derivative of flurbiprofen or ketorolac
    Patent number: 6646003
    Abstract: The topical use of certain flurbiprofen amide derivatives and ketorolac amide derivatives to treat ophthalmic angiogenesis-related and inflammatory disorders of the posterior segment of the eye is disclosed.
    Type: Grant
    Filed: March 7, 2002
    Date of Patent: November 11, 2003
    Assignee: Alcon, Inc.
    Inventors: Gustav Graff, Mark R. Hellberg, John M. Yanni
  • Lipoxin A4 and its analogs for the treatment of dry eye
    Patent number: 6645978
    Abstract: Ophthalmic compositions containing Lipoxin A4 and its analogs and methods of their use for treating dry eve are disclosed.
    Type: Grant
    Filed: March 23, 2001
    Date of Patent: November 11, 2003
    Assignee: Alcon, Inc.
    Inventors: Daniel A. Gamache, Gustav Graff, Mark R. Hellberg, Peter G. Klimko, John M. Yanni
  • Method of treating vascular endothelial growth factor mediated vascular disorders
    Publication number: 20030207941
    Abstract: The use of amfenac and derivatives, including nepafenac, to treat vascular endothelial growth factor mediated vascular disorders.
    Type: Application
    Filed: April 16, 2003
    Publication date: November 6, 2003
    Inventors: David P. Bingaman, Michael A. Kapin, Daniel A. Gamache, Gustav Graff, John M. Yanni
  • Method of treating neurodegenerative disorders of the retina and optic nerve head
    Patent number: 6638976
    Abstract: The use of 3-benzolphenylacetic acids and derivatives, including nepafenac, to treat neurodegenerative retinal disorders is disclosed.
    Type: Grant
    Filed: August 13, 2001
    Date of Patent: October 28, 2003
    Assignee: Alcon, Inc.
    Inventors: Daniel A. Gamache, Gustav Graff, John M. Yanni, Michael A. Kapin
  • Method of treating angiogenesis-related disorders
    Publication number: 20030187072
    Abstract: The use of 3-benzolphenylacetic acids and derivatives, including nepafenac, to treat angiogenesis-related disorders, including ophthalmic angiogenesis-related disorders such as diabetic retinopathy and exudative macular degeneration, is disclosed.
    Type: Application
    Filed: February 14, 2003
    Publication date: October 2, 2003
    Inventors: Michael A. Kapin, David P. Bingaman, Daniel A. Gamache, Gustav Graff, John M. Yanni
  • Methods for treating dry eye
    Publication number: 20030109509
    Abstract: Methods of treating dry eye by administering fixed combinations of MUC-1 secretagogues, such as HETE derivatives, and anti-inflammatory steroids are disclosed.
    Type: Application
    Filed: September 26, 2002
    Publication date: June 12, 2003
    Applicant: Alcon, Inc.
    Inventors: Daniel A. Gamache, John M. Yanni, Barry F. Van Duzee
  • Methods for treating dry eye
    Publication number: 20030109488
    Abstract: Methods of treating dry eye by administering fixed combinations of MUC-1 secretagogues, such as HETE derivatives, and lacrimal gland stimulants are disclosed.
    Type: Application
    Filed: September 26, 2002
    Publication date: June 12, 2003
    Applicant: Alcon, Inc.
    Inventors: John M. Yanni, Daniel A. Gamache
  • Methods for treating dry eye
    Publication number: 20030109508
    Abstract: Methods of treating dry eye by administering fixed combinations of MUC-1 secretagogues, such as HETE derivatives, and androgen compounds are disclosed.
    Type: Application
    Filed: September 26, 2002
    Publication date: June 12, 2003
    Applicant: Alcon, Inc.
    Inventors: John M. Yanni, Daniel A. Gamache
  • Compositions and methods for treating otic, ophthalmic and nasal infections
    Publication number: 20030069253
    Abstract: Ophthalmic, otic and nasal compositions containing a new class of antibiotics (e.g., moxifloxacin) are disclosed. The compositions preferably also contain one or more anti-inflammatory agents. The compositions may be utilized to treat ophthalmic, otic and nasal conditions by topically applying the compositions to the affected tissues. The compositions and methods of the invention are particularly useful in the treatment of acute otitis externa infections attributable to one or both of two newly identified Microbacterium species, Microbacterium otitidis and Microbacterium alconae.
    Type: Application
    Filed: September 24, 2002
    Publication date: April 10, 2003
    Inventors: Gerald Cagle, Robert L. Abshire, David W. Stroman, Celeste H. McLean, Linda L. Clark, John M. Yanni
  • Compositions and methods for treating otic, ophthalmic and nasal infections
    Patent number: 6509327
    Abstract: Ophthalmic, otic and nasal compositions containing a new class of antibiotics (e.g., moxifloxacin) are disclosed. The compositions preferably also contain one or more anti-inflammatory agents. The compositions may be utilized to treat ophthalmic, otic and nasal conditions by topically applying the compositions to the affected tissues. The compositions and methods of the invention are particularly useful in the treatment of acute otitis externa infections attributable to one or both of two newly identified Microbacterium species, Microbacterium otitidis and Microbacterium alconae.
    Type: Grant
    Filed: May 19, 2000
    Date of Patent: January 21, 2003
    Assignee: Alcon Manufacturing, Ltd.
    Inventors: Gerald Cagle, Robert L. Abshire, David W. Stroman, Celeste H. McLean, Linda L. Clark, John M. Yanni
  • Method for treating dry eye disorders
    Publication number: 20030008853
    Abstract: 22,29-epoxy-3,4,6,7,29-pentahydroxy-,(3&agr;,4&bgr;,5&agr;,6&agr;,7&bgr;,14&bgr;,22S)-stigmastan-15-one is useful for treating dry eye disorders and other disorders requiring the wetting of the eye.
    Type: Application
    Filed: May 17, 2002
    Publication date: January 9, 2003
    Applicant: Alcon, Inc.
    Inventors: John M. Yanni, Daniel A. Gamache
  • Use of NF-kappabeta inhibitors to treat dry eye disorders
    Publication number: 20030008854
    Abstract: NF-&kgr;B inhibitors are useful for treating dry eye disorders and other disorders requiring the wetting of the eye.
    Type: Application
    Filed: May 17, 2002
    Publication date: January 9, 2003
    Applicant: Alcon, Inc.
    Inventors: Daniel A. Gamache, John M. Yanni
  • Antibiotic compositions for treatment of the eye, ear and nose
    Publication number: 20020193370
    Abstract: Ophthalmic, otic and nasal compositions containing a new class of antibiotics (e.g., moxifloxacin) are disclosed. The compositions preferably also contain one or more anti-inflammatory agents. The compositions may be utilized to treat ophthalmic, otic and nasal conditions by topically applying the compositions to the affected tissues.
    Type: Application
    Filed: July 22, 2002
    Publication date: December 19, 2002
    Inventors: Gerald Cagle, Robert L. Abshire, David W. Stroman, John M. Yanni